NASDAQ: COYA
Coya Therapeutics Inc Stock Ownership - Who owns Coya Therapeutics?

Insider buying vs selling

Have Coya Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David S. SnyderChief Financial Officer2024-11-141,800$7.19
$12.93kBuy
Arun SwaminathanChief Executive Officer2024-11-135,000$7.36
$36.80kBuy
Fred GrossmanChief Medical Officer2024-11-112,710$7.37
$19.97kBuy
Arun SwaminathanChief Executive Officer2024-11-115,000$7.34
$36.69kBuy

1 of 1

COYA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when COYA insiders and whales buy or sell their stock.

COYA Shareholders

What type of owners hold Coya Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Dme Capital Management LP9.84%1,646,440$9.27MInstitution
Aigh Capital Management LLC7.08%1,183,780$6.66MInstitution
Howard Berman5.68%949,338$5.34MInsider
Bertex LLC5.62%939,338$5.29MInsider
Vanguard Group Inc5.03%840,471$4.73MInstitution
CM Management LLC1.20%200,000$1.13MInstitution
Dauntless Investment Group LLC1.00%167,378$942.34kInstitution
Wilbur L. Ross Jr.0.99%165,016$929.04kInsider
Geode Capital Management LLC0.93%155,829$877.32kInstitution
Blackrock Inc0.50%83,795$471.77kInstitution

1 of 3

COYA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
COYA27.88%12.80%Net Buying
IVVD43.45%56.55%Net Selling
HLVX69.66%30.34%Net Selling
MGNX69.37%30.63%Net Selling
WHWK44.74%55.26%Net Buying

Coya Therapeutics Stock Ownership FAQ

Who owns Coya Therapeutics?

Coya Therapeutics (NASDAQ: COYA) is owned by 27.88% institutional shareholders, 12.80% Coya Therapeutics insiders, and 59.32% retail investors. Howard Berman is the largest individual Coya Therapeutics shareholder, owning 949,338.00 shares representing 5.68% of the company. Howard Berman's Coya Therapeutics shares are currently valued at $5.34M.

If you're new to stock investing, here's how to buy Coya Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.